Medicamen Biotech Limited
Medicamen Biotech Limited (MEDICAMEQ-EQ) live share price today at NSE / BSE
Thu, 17 Sept 2026, 02:30 PM
About MEDICAMEQ-EQ
Medicamen Biotech Ltd is an Indian pharmaceutical manufacturing company specializing in the development, production, and marketing of generic formulations across therapeutic segments such as antibiotics, anti-malarials, and anti-retrovirals. Established with a focus on high-quality, affordable medicines, the company caters to both domestic and international markets—including collaborations with government bodies and non-governmental organizations for healthcare initiatives.
52 Week Range
Current Signal
green
Open
INR 345.50
High
INR 363.90
Low
INR 340.05
Prev. Close
INR 345.50
Volume
1,28,639
Avg. Volume (7D)
1,96,102
Avg. Volume (10D)
1,65,345
Latest Signal
BuyBuy Price
INR 246.4
Close Price
INR 248.88
Change
47.69%
Stoploss
INR 239.0
Signal Date
2026-08-28
Hold
Yes
Pattern
Doji
Company Snapshot
| CIN | L74899DL1993PLC056594 |
| Industry | Pharmaceuticals |
| Market Lot | 1 |
| Impact Cost | 0.28% |
| Listing Date | 09 Oct 1995 |
| BC Record Date | BC 20/09/2024-26/09/2024 |
| Registered Address | 1506, Chiranjiv Tower, 43, Nehru Place, |
| Auditor | Rai Qimat & Associates |
Registrar
Board of Directors
Today Share Price
Medicamen Biotech Limited
| Particulars | Details |
|---|---|
| Opening Price | INR 345.50 |
| Previous Closing Price | INR 345.50 |
| Volume of Medicamen Biotech Limited | 1,28,639 |
| Value of Share | — |
Today NSE Share Price
Medicamen Biotech Limited
| Particulars | Details |
|---|---|
| Live Share Price NSE India | INR 346.30 |
| Previous Closing Price | INR 345.50 |
| Open Price | INR 345.50 |
| High | INR 363.90 |
| Low | INR 340.05 |
Today BSE Share Price
Medicamen Biotech Limited
| Particulars | Details |
|---|---|
| Live Share Price BSE India | INR 346.30 |
| Previous Closing Price | INR 345.50 |
| Open Price | INR 345.50 |
| High | INR 363.90 |
| Low | INR 340.05 |
Medicamen Biotech Limited
Medicamen Biotech Ltd is an Indian pharmaceutical manufacturing company specializing in the development, production, and marketing of generic formulations across therapeutic segments such as antibiotics, anti-malarials, and anti-retrovirals. Established with a focus on high-quality, affordable medicines, the company caters to both domestic and international markets—including collaborations with government bodies and non-governmental organizations for healthcare initiatives.
The company operates state-of-the-art manufacturing facilities certified by global regulatory authorities, supporting exports to over 45 countries in Asia, Africa, and Latin America. Medicamen Biotech is committed to innovation in product development and has a robust pipeline emphasizing growth in chronic and specialty therapies. The company maintains a strong record in regulatory compliance and quality assurance, contributing to its stable reputation among institutional and private healthcare players.
Frequently Asked Questions – StockYaari Stock Page
Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.
Final Thoughts
Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.
Track. Analyse. Outperform.
Your performance, our priority.

Platform Performance
(vs NIFTY 50)
Total Return
+24.35%
Outperformance
+12.41%
Accuracy
78%
Join 31,000+ active traders

Ready to unlock premium signals?
Sign in with your mobile number and start trading smarter today.

